Affibody-based nanoprobes for HER2-expressing cell and tumor imaging - Wikidata - awgldk - TriplyDB

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

http://www.wikidata.org/entity/Q34545516

about

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer Prostate cancer relevant antigens and enzymes for targeted drug delivery Optical imaging probes in oncology Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis Nanoparticles for Improving Cancer Diagnosis.In vivo cancer targeting and imaging-guided surgery with near infrared-emitting quantum dot bioconjugates Short peptides as biosensor transducers.Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy Translational genomics: the challenge of developing cancer biomarkers.Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.Generation of affibody molecules specific for HPV16 E7 recognition Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.Near-infrared quantum dots for HER2 localization and imaging of cancer cells.Antibody-targeted nanoparticles for cancer therapy.Quantum dots in cancer therapy.Image-guided resection of malignant gliomas using ﬂuorescent nanoparticles.Clearance Pathways and Tumor Targeting of Imaging Nanoparticles A small-molecule dye for NIR-II imaging.A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer.Imaging Translational and Post-Translational Gene Regulatory Dynamics in Living Cells with Antibody-Based Probes.Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.Passive and active targeting of quantum dots for whole-body fluorescence imaging of breast cancer xenografts.Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging.A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects Development of a high quantum yield dye for tumour imaging.Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer Aptamer-conjugated magnetic nanoparticles enable efficient targeted detection of integrin αvβ3 via magnetic resonance imaging.Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells.Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications.In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis.

P2860

Q26828849-4910A42A-48F4-4263-A021-34170DD8D008 Q27013843-407DB6B7-92B7-41ED-9DBA-FE404FD7F86A Q28067824-28D4C84B-EB3C-430C-A2F9-6210CAF71D06 Q30303040-21A1987C-04A5-4211-B03F-4075BAC3952E Q30442412-07AA041C-772B-47DF-91B0-A1A50861CBEC Q30524331-2A80279D-DE8E-48E8-A33B-77B28CCBCBA6 Q31043462-CC150E53-89D8-4077-902F-ABE4370FF7A5 Q34698633-ED2F7D4B-2198-47B7-9FC1-312918C49454 Q35086515-0786B899-5221-4463-A073-1D0C7BFCBFDA Q35694362-15AD6908-B244-4BAF-9690-7540F98BE7A7 Q35851983-9AE25592-0489-4E85-83B5-BE36510205EE Q36141929-88975F80-0F8C-40EF-9D64-826BC22C5F23 Q36585770-837EE322-EA14-4ED8-B939-F8BEB948AC4D Q36607583-AFFB1B0E-ABF2-48C1-BCE8-EFBDED19021D Q36845960-B6E2552C-1C03-44C0-AFE5-D417B5CB1BDA Q37202303-9054F6ED-2409-4261-B18A-9549AD1661BB Q37624379-4F6EA643-4E4F-46BB-970F-3067EACD41A9 Q37626377-C3FE843A-7D0A-4DA7-A36D-DF1B5D7C8562 Q37633071-3F33D032-0238-4D1C-B42A-F33B6CA42266 Q37641853-6AAE5DAC-B640-434F-9279-946F152AAE62 Q37851969-19E160DD-53BB-4F5B-9613-9AE338597F71 Q37968640-2D1B9BD9-DBCE-4C3C-BAD2-3C9906C71287 Q38078875-A9EBD2BD-5C3D-43FB-9A92-6CF42376FDAA Q38543331-63C1D3B1-6A2D-4C46-86B4-0FC11E73D2F8 Q38817659-AA251E42-709C-4AD4-9A7E-077E1660275F Q38985097-3981D3F9-C3CC-460E-8905-C51446B8EDA8 Q39209269-0183DC99-B615-4CCD-BC22-8C882FAFC019 Q39227190-D4026D64-3FA7-485E-B8B7-B93C3150CB68 Q39298731-3A63E174-96E6-44A3-AD81-904AB0DED338 Q39373444-35332D52-9215-4F12-B958-BA24C32ED083 Q39675461-6FFDE50B-C104-4268-96BD-9E39A4963C30 Q42278676-8A01FC8E-9080-43FE-BA34-EB942F40040D Q42660155-8C336A4F-3651-45F3-8E3B-FF10E47ABE8C Q46629894-4CF739CF-01A4-4005-9A19-84780BDBC3F5 Q51353652-107C8AE6-1144-472C-AD66-C6AEF0B7C869 Q51571874-6DEFA768-BDCD-4948-AD87-E62DD4252CC1 Q51676931-428391C0-4A21-4234-BEEE-5845D5C0275F Q52600754-9A2E7C47-40EB-44AB-A2F5-EC2E87BC66DC

P2860

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

http://www.wikidata.org/entity/Q34545516

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@ast

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@en

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@nl

type

label

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@ast

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@en

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@nl

prefLabel

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@ast

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@en

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@nl

P1433

Q34545516-408F59CC-49D8-4DEB-88A7-7B05F2DBC1FF

P1476

Q34545516-6F87DB63-CE11-42B2-8E14-58DEC827AEBF

P2093

Q34545516-005FD6BC-CA13-4A92-AA0C-B64405D7CABB

Q34545516-15EEEE1F-DD0E-4FF3-84EA-BFA8B61EFE7D

Q34545516-2CA13404-3B33-4C5A-8AA9-83F0ED0856BF

Q34545516-2D107AD8-6BDA-42E7-898B-EB46DAE7016D

Q34545516-8B9D3EAA-8B25-44C5-9A8C-B96E797DFBFC

Q34545516-CFB080B2-E961-4F2F-B645-B1C329DEE0F4

P2860

Q34545516-0320D531-7FD5-49F5-B5AD-09C1F9648FD3

Q34545516-06962634-FFB9-4A8B-A365-D1AB58191FDF

Q34545516-1A6F5BD8-5626-41DD-A97B-17F7DBF4FD44

Q34545516-1C39384B-EAC0-4352-BC56-0C8717CB3499

Q34545516-1E55D40C-AB55-4C91-BA9F-65FB3A5F5B2E

Q34545516-2CE479A0-06B7-4CF1-8EDF-1D675926C29A

Q34545516-319A3D2D-FA16-446D-83DE-16C2F7F8BDFC

Q34545516-34599274-8B2D-463D-AC93-E436710060F0

Q34545516-37097A9F-0DFB-4F9B-B920-1A8C9C21E432

Q34545516-37A13670-94AC-412F-893D-AF2BBA5CCFFC

P304

Q34545516-DBD1D4A8-7E60-4493-A18D-CBB713AB42FC

P31

Q34545516-F942A67A-54F4-406D-B062-3C960ABE1F2E

P356

Q34545516-09442CCE-B695-433F-9E27-999C844DB728

P433

Q34545516-7C01D6B4-394D-45D6-957A-78A52C2AD27A

P478

Q34545516-E6BA4037-4373-4887-8ACA-8902092C8C47

P50

Q34545516-DAB32079-C561-4139-A975-E5115C344940

P577

Q34545516-CD6B2362-DFC0-411E-92F4-393919B0107A

P5875

Q34545516-2C52A896-F88C-4AB4-90E7-C519861B6EBD

P698

Q34545516-08B82623-2E6F-4F6E-851A-2A56DDCC06C3

P932

Q34545516-7EC200F1-07E8-4334-8CB3-B2749757D911

P356

J.BIOMATERIALS.2010.11.053

P1433

P1476

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

@en

P2093

Gang Ren

http://www.w3.org/2001/XMLSchema#string

Jinhao Gao

http://www.w3.org/2001/XMLSchema#string

Kai Chen

http://www.w3.org/2001/XMLSchema#string

Sanjiv S Gambhir

http://www.w3.org/2001/XMLSchema#string

Zhen Cheng

http://www.w3.org/2001/XMLSchema#string

Zheng Miao

http://www.w3.org/2001/XMLSchema#string

P2860

Quantum dots for live cells, in vivo imaging, and diagnostics

Carbon nanotubes as photoacoustic molecular imaging agents in living mice.

Renal clearance of quantum dots.

In vivo cancer targeting and imaging with semiconductor quantum dots

Design considerations for tumour-targeted nanoparticles.

Engineering novel binding proteins from nonimmunoglobulin domains.

Tumor imaging using a picomolar affinity HER2 binding affibody molecule.

Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging.

Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications.

Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy

P304

2141-2148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2010.11.053

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49673416

http://www.w3.org/2001/XMLSchema#string

P698

21147502

http://www.w3.org/2001/XMLSchema#string

P932

3032351

http://www.w3.org/2001/XMLSchema#string